PortfoliosLab logo
ABCL vs. SGMO
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between ABCL and SGMO is 0.40, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


Performance

ABCL vs. SGMO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in AbCellera Biologics Inc. (ABCL) and Sangamo Therapeutics, Inc. (SGMO). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Daily Std Dev

ABCL:

59.42%

SGMO:

179.95%

Max Drawdown

ABCL:

-8.22%

SGMO:

-15.00%

Current Drawdown

ABCL:

-7.31%

SGMO:

-2.75%

Fundamentals

Market Cap

ABCL:

$605.80M

SGMO:

$160.48M

EPS

ABCL:

-$0.55

SGMO:

-$0.49

PS Ratio

ABCL:

21.02

SGMO:

2.78

PB Ratio

ABCL:

0.57

SGMO:

7.05

Total Revenue (TTM)

ABCL:

$18.88M

SGMO:

$57.32M

Gross Profit (TTM)

ABCL:

-$71.35M

SGMO:

$52.61M

EBITDA (TTM)

ABCL:

-$164.12M

SGMO:

-$46.71M

Returns By Period


ABCL

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

SGMO

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

ABCL vs. SGMO — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ABCL
The Risk-Adjusted Performance Rank of ABCL is 1313
Overall Rank
The Sharpe Ratio Rank of ABCL is 1212
Sharpe Ratio Rank
The Sortino Ratio Rank of ABCL is 1212
Sortino Ratio Rank
The Omega Ratio Rank of ABCL is 1515
Omega Ratio Rank
The Calmar Ratio Rank of ABCL is 1919
Calmar Ratio Rank
The Martin Ratio Rank of ABCL is 66
Martin Ratio Rank

SGMO
The Risk-Adjusted Performance Rank of SGMO is 6868
Overall Rank
The Sharpe Ratio Rank of SGMO is 6262
Sharpe Ratio Rank
The Sortino Ratio Rank of SGMO is 7777
Sortino Ratio Rank
The Omega Ratio Rank of SGMO is 7777
Omega Ratio Rank
The Calmar Ratio Rank of SGMO is 6565
Calmar Ratio Rank
The Martin Ratio Rank of SGMO is 6060
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

ABCL vs. SGMO - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for AbCellera Biologics Inc. (ABCL) and Sangamo Therapeutics, Inc. (SGMO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.



Loading data...

Dividends

ABCL vs. SGMO - Dividend Comparison

Neither ABCL nor SGMO has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

ABCL vs. SGMO - Drawdown Comparison

The maximum ABCL drawdown since its inception was -8.22%, smaller than the maximum SGMO drawdown of -15.00%. Use the drawdown chart below to compare losses from any high point for ABCL and SGMO. For additional features, visit the drawdowns tool.


Loading data...

Volatility

ABCL vs. SGMO - Volatility Comparison


Loading data...

Financials

ABCL vs. SGMO - Financials Comparison

This section allows you to compare key financial metrics between AbCellera Biologics Inc. and Sangamo Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00M200.00M250.00M300.00M350.00MAprilJulyOctober2021AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober
5.05M
7.55M
(ABCL) Total Revenue
(SGMO) Total Revenue
Values in USD except per share items